Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)

This study has been completed.
Sponsor:
Collaborators:
Pfizer
Merck Sharp & Dohme Corp.
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00973466
First received: September 4, 2009
Last updated: January 12, 2011
Last verified: January 2011

September 4, 2009
January 12, 2011
May 2009
May 2010   (final data collection date for primary outcome measure)
Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00973466 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern

There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.

Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months

  • HIV Infections
  • Neisseria Gonorrhoeae
  • Chlamydia Trachomatis
  • Herpes Simplex
Not Provided
HIV-infection
All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
June 2010
May 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV-infection
  • Attending the Clinic for Infectious Diseases from May 09 to November 09
  • Sexually active during the last 12 months
  • Written informed consent

Exclusion Criteria:

  • None
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00973466
KEK26/09
No
Hansjakob Furrer, Leitender Arzt, University Hospital Inselspital, Berne
University Hospital Inselspital, Berne
  • Pfizer
  • Merck Sharp & Dohme Corp.
Principal Investigator: Hansjakob Furrer, MD University Hospital Berne
University Hospital Inselspital, Berne
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP